Prostate Cancer Trial, Recruiting NCT06315595 Sponsor: Mayo Clinic Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06315595
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults (18 years of age or older)

Who may not be able to join:

  • People who have a cardiac pacemaker, as this is not compatible with MRI scanning
  • People who experience claustrophobia (fear of enclosed spaces), which may make MRI scanning difficult
  • People who have an implanted medical device that is only considered safe for MRI machines operating at 1.5 Tesla strength, but not at the higher 3 Tesla strength used in this trial
  • People whose hip replacement or similar metal implant is likely to cause significant interference with MRI image quality (confirm with trial site)
  • People who do not meet standard safety requirements for clinical MRI scanning for any other reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stephen J. Riederer, PhD, Mayo Clinic in Rochester

Phone: 855-776-0015

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
30 September 2015
Est. completion
30 September 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Improved performance in contrast-enhanced magnetic resonance imaging (MRI) as used for angiography and perfusion

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov